Episode Details
Back to Episodes
INNOVATE Q1 2026: Infrastructure & Life Sciences Shine
Description
Innovates Q1 2026 earnings show a robust start, with consolidated revenue up 33% to $364.8M and adjusted EBITDA doubling to $19.7M. Infrastructure segment, led by DBM Global, drove growth with a 35% increase in revenue and a healthy backlog of $1.8B. Life sciences saw progress with regulatory wins and increased demand, while Spectrum faced headwinds but is expanding low-power TV licenses and advancing carrier partnerships. Corporate cash stands at $134.6M, with debt at $699M. Momentum in infrastructure and life sciences sets up potential upside as visibility improves.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/b614adc70020c485